Related Experiment Videos

An MRI and MRS study of Pelizaeus-Merzbacher disease

A Nezu1, S Kimura, S Takeshita

  • 1Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan.

Pediatric Neurology
|May 20, 1998
PubMed

Insights

Classical Pelizaeus-Merzbacher disease patients with duplicated proteolipid protein gene showed consistent T2-weighted MRI type I lesions. Follow-up MRI and spectroscopy revealed stable white matter, suggesting preserved axons and no sclerosis.

Area of Science:

  • Neuroimaging
  • Genetics
  • Neurology

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a rare, inherited leukodystrophy.
  • Previous T2-weighted MRI studies classified white matter lesions into three subtypes.
  • The proteolipid protein (PLP) gene is frequently implicated in PMD.

Purpose of the Study:

  • To investigate the MRI findings in classical Pelizaeus-Merzbacher disease patients with duplicated PLP gene.
  • To assess the stability of white matter lesions over time using serial MRI.
  • To evaluate white matter metabolite changes using proton magnetic resonance spectroscopy (MRS).

Main Methods:

  • Four male patients with classical PMD and duplicated PLP gene underwent T2-weighted MRI.
  • Follow-up MRI was conducted after 5 years in three patients.
  • Proton magnetic resonance spectroscopy was performed on three patients.

Main Results:

  • All four patients invariably presented with type I MRI lesions (diffusely hemispheric and corticospinal).
  • Follow-up MRI showed unchanged white matter volume and lesion distribution over 5 years.
  • Proton MRS revealed no abnormal peaks, indicating stable white matter composition.

Conclusions:

  • The duplicated PLP gene in classical PMD consistently leads to type I MRI lesion patterns.
  • Stable MRI findings correlate with clinical stability and lack of neurologic regression.
  • The absence of sclerosis and preservation of axons are consistent with the observed imaging findings.

Related Concept Videos